Search Results - Seki M

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Optimizing Antimicrobial Use in Japan: Strategies for Dosage, Combination Therapy, De-Escalation, Oral Switching, Duration, and Guideline Adherence by Seki M

    Get full text
    Article


  2. 2

    Differences in Treatment Patterns and Patient Characteristics Between COVID-19 Patients Treated with Nirmatrelvir/Ritonavir and Ensitrelvir in Japan by Seki M

    Published in International Journal of General Medicine (2024-08-01)
    Get full text
    Article


  3. 3

    Severe Influenza Patients Who Received Ventilator Management During the 2024 to 2025 Major Influenza-Endemic Season in a Tertiary Hospital in Japan by Seki M, Shimada D

    Published in International Medical Case Reports Journal (2025-05-01)
    Get full text
    Article


  4. 4

    Severe Respiratory Syncytial Virus Infections in Elderly Persons During the COVID-19 Pandemic by Shimada D, Seki M

    Published in Infection and Drug Resistance (2024-08-01)
    Get full text
    Article


  5. 5

    Effectiveness of Drip Infusion of Lascufloxacin, a Novel Fluoroquinolone Antibiotic, for Patients with Pneumonia Including Chronic Lung Disease Exacerbations and Lung Abscesses by Shimada D, Seki M

    Published in Infection and Drug Resistance (2024-03-01)
    Get full text
    Article


  6. 6

    Rhinovirus-Infected Patients in the COVID-19 Pandemic Period by Watanabe Y, Kamioka Y, Seki M

    Published in Infection and Drug Resistance (2021-02-01)
    Get full text
    Article


  7. 7

    Detection of Representative Mutant Strains and a Case of Prolonged Infection by SARS-CoV-2 with Spike 69/70 Deletion in Japan by Takano K, Watanabe Y, Hariu M, Seki M

    Published in Infection and Drug Resistance (2021-07-01)
    Get full text
    Article


  8. 8

    COVID-19 and Listeria Meningitis Treated by Ampicillin, Sulfamethoxazole/Trimethoprim and Meropenem by Seki M, Karaushi H, Arai N, Hayashi T, Mitsutake K

    Published in Infection and Drug Resistance (2023-07-01)
    Get full text
    Article


  9. 9

    Clinical Differences Between Survivors and Non-Survivors of Ventilator-Associated Pneumonia: The Roles of Sulbactam/Ampicillin and Methicillin-Resistant Staphylococcus aureus by Seki M, Takimoto A, Inoue M, Niiyama K, Masuoka A, Kotajima F

    Published in Infection and Drug Resistance (2024-12-01)
    Get full text
    Article


  10. 10

    Clinical Features of Patients with COVID-19 Recurrence During Hospitalization in the Omicron Variant Surge by Seki M, Kubosawa C, Ono M, Kamoshita F, Shimizu A, Mitsutake K

    Published in Infection and Drug Resistance (2024-11-01)
    Get full text
    Article


  11. 11

    Sinobronchial Syndrome Patients with Suspected Non-Tuberculous Mycobacterium Infection Exacerbated by Exophiala dermatitidis Infection by Watanabe Y, Sano H, Konno S, Kamioka Y, Hariu M, Takano K, Yamada M, Seki M

    Published in Infection and Drug Resistance (2022-03-01)
    Get full text
    Article


  12. 12

    Polymerase chain reaction-based active surveillance of MRSA in emergency department patients by Seki M, Takahashi H, Yamamoto N, Hamaguchi S, Ojima M, Hirose T, Yoshiya K, Ogura H, Shimazu T, Tomono K

    Published in Infection and Drug Resistance (2015-05-01)
    Get full text
    Article


  13. 13

    Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analys... by Muro S, Seki M, Hurst JR, Petullo D, Marshall J, Bowen K, Darken PF, Duncan EA, Megally A, Patel M

    Published in International Journal of COPD (2024-12-01)
    Get full text
    Article


Search Tools: